Specialty Pharmacy News

Image description

QuintilesIMS report discusses pharmacists’ roles regarding precision medicines

“Pharmacists need to understand what’s happening around them regarding the availability of precision medicines and their profiles,” Murray Aitken, executive director of the Quintiles IMS Institute and co-author of the report, said during the International Pharmaceutical Federation 6th Pharmaceutical Sciences World Congress.

Image description

J&J: 10 products with “blockbuster potential” to be filed by 2021

During an analyst meeting, the company also said it will share its plans to continue driving sustainable growth by leveraging its strong portfolio of core blockbuster products, the “industry-leading” productivity of its innovation model, and the pending acquisition of Swiss-based biotech company Actelion.

Image description

Fresenius Kabi introduces pediatric cancer generic

Clofarabine injection is a purine nucleoside metabolic inhibitor indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.

Image description

FDA approves Pfizer bladder cancer drug

Bavencio (avelumab) Injection is intended for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

Image description

Diplomat acquires WRB communications

WRB will join Envoy Health Management as part of Diplomat’s offering of commercialization support services for manufacturers and biotech firms, among other service companies.